Aphios Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Latest Deal Amount
-
$1.1K
- Investors
-
6
Aphios General Information
Description
Developer of cannabis-based drugs designed to treat peripheral nervous system disorders. The company's drugs prevent and treat certain cancers, infectious diseases, and Central Nervous System (CNS) disorders such as Alzheimer's, enabling doctors to treat patients with the nervous disease.
Contact Information
Website
www.aphios.comCorporate Office
- 87 Main Street
- North Reading, MA 01864
- United States
Corporate Office
- 87 Main Street
- North Reading, MA 01864
- United States
Aphios Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Equity Crowdfunding | 11-Oct-2024 | $1.1K | Announced | Generating Revenue | ||
4. Equity Crowdfunding | 30-Sep-2021 | Cancelled | Generating Revenue | |||
3. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
2. Grant | 01-Jul-2019 | $16.8M | $48.2K | Completed | Generating Revenue | |
1. Equity Crowdfunding | 31-Jan-2019 | $48.2K | $48.2K | Completed | Generating Revenue |
Aphios Comparisons
Industry
Financing
Details
Aphios Competitors (16)
One of Aphios’s 16 competitors is Allorion Therapeutics, a Venture Capital-Backed company based in Natick, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Allorion Therapeutics | Venture Capital-Backed | Natick, MA | ||||
Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
Beactica Therapeutics | Venture Capital-Backed | Uppsala, Sweden | ||||
Amal Therapeutics | Formerly VC-backed | Geneva, Switzerland | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD |
Aphios Patents
Aphios Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240335575-A1 | Method and apparatus for inactivating pathogens in units of whole blood using superparamagnetic nanoparticles coated with chemiluminescence reagents and broad-spectrum anti-viral therapeutics | Pending | 20-Oct-2021 | ||
US-20240350691-A1 | Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma | Pending | 12-Oct-2021 | ||
US-12071419-B2 | Thermal conversion of cbda and other carboxylic cannabinoids | Active | 23-Apr-2021 | ||
US-20220313610-A1 | Methods for and products from encapsulation of drugs in nanoparticles in a microgravity environment | Inactive | 04-Apr-2021 | ||
US-20240252437-A1 | Methods for and products from encapsulation of drugs in nanoparticles in a microgravity environment | Pending | 04-Apr-2021 | A61K9/1277 |
Aphios Signals
Aphios Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Cancer Institute | Government | |||
National Center For Complementary And Integrative Health | Government | |||
National Heart, Lung, and Blood Institute | Government | |||
National Institute for Allergy and Infectious Disease | Government | |||
National Institute on Drug Abuse (NIDA) | Government |
Aphios FAQs
-
When was Aphios founded?
Aphios was founded in 2018.
-
Where is Aphios headquartered?
Aphios is headquartered in North Reading, MA.
-
What is the size of Aphios?
Aphios has 6 total employees.
-
What industry is Aphios in?
Aphios’s primary industry is Biotechnology.
-
Is Aphios a private or public company?
Aphios is a Private company.
-
What is the current valuation of Aphios?
The current valuation of Aphios is
. -
What is Aphios’s current revenue?
The current revenue for Aphios is
. -
How much funding has Aphios raised over time?
Aphios has raised $49.3K.
-
Who are Aphios’s investors?
National Cancer Institute, National Center For Complementary And Integrative Health, National Heart, Lung, and Blood Institute, National Institute for Allergy and Infectious Disease, and National Institute on Drug Abuse (NIDA) are 5 of 6 investors who have invested in Aphios.
-
Who are Aphios’s competitors?
Allorion Therapeutics, Aro Biotherapeutics, Beactica Therapeutics, Amal Therapeutics, and NexImmune are some of the 16 competitors of Aphios.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »